Jolie Ringash

Dr. Jolie Ringash


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2024 in Oral Oncology
Verified
Journal Article
Closed access
SASulaiman Alsheikh
Sulaiman Alsheikh
JSJie Su
Jie Su
BOBrian O’sUllivan
Brian O’sUllivan
JRJolie Ringash
Jolie Ringash
JWJohn N Waldron
John N Waldron
SHShao Hui Huang
Shao Hui Huang

3 September 2025 in The Lancet Regional Health - Americas
Verified
Journal Article
Open access
JMJohn Mohan Mathew
John Mohan Mathew
JRJolie Ringash
Jolie Ringash
JSJie Su
Jie Su
WLWilfred Levin
Wilfred Levin
SBScott Bratman
Scott Bratman
PWPhilip Wong
Philip Wong
Radiation late toxicities (RLTs) are complications of curative-intent radiotherapy (RT) for head and neck cancer (HNC) and are increasingly relevant due to younger age at diagnosis and improved survival outcomes. We conducted a cohort study of HNC patients who received ≥50 Gy as part of curative treatment between January 2003 and December 2020 at a Canadian quaternary cancer center. Risk factors for severe RLTs (≥RTOG Grade 3) were evaluated using time-to-event analyses. Actuarial rates of RLT and overall survival (OS) were estimated using competing risk and Kaplan–Meier methods, respectively. Cox proportional hazard models identified factors associated with RLT and OS. Among 7622 patients, 12.6% (n = 958) developed RLTs without disease progression, with a 5-year actuarial incidence of 16% (95% CI: 15–16). A survivors subgroup (n = 4650) with ≥2 years of follow-up and no recurrence was also identified. Modifiable risk factors for RLTs included RT technique, dose, neck irradiation, neck dissection, smoking status, and chemotherapy (p ≤ 0.012). Non-modifiable factors included younger age, female sex, and oral cavity primaries (p ≤ 0.012). In multivariable analysis, RLTs were associated with increased mortality (HR = 2.1, 95% CI: 1.8–2.5, p < 0.001), but RLT's impact on OS was lessened among patients referred to the Adult Radiation Late Effects Clinic (ARLEC) (HR = 1.7, 95% CI: 1.3–2.4). RLTs are common and associated with worse survival among HNC survivors. Identification of modifiable risk factors provides opportunities for prevention. Multidisciplinary management of RLTs in specialized clinics may help improve the outcomes in this growing survivorship population. No external funding was utilized for this study.

21 April 2025 in Oral Oncology
Verified
Journal Article
Closed access
Marc Vincent Ngo BarcelonaMarc Vincent Ngo Barcelona
Marc Vincent Ngo Barcelona
JWJohn Waldron
John Waldron
BOBrian O’Sullivan
Brian O’Sullivan
JSJie Su
Jie Su
SBScott Bratman
Scott Bratman
SHShao Hui Huang
Shao Hui Huang

12 March 2025 in Oral Oncology
Verified
Journal Article
Closed access
JMJohn Mohan Mathew
John Mohan Mathew
IBIonut Busca
Ionut Busca
ZBZeynep Baskurt
Zeynep Baskurt
MGMeredith Giuliani
Meredith Giuliani
NQNaa Kwarley Quartey
Naa Kwarley Quartey
JRJolie Ringash
Jolie Ringash

17 November 2025 in Current Oncology
Verified
Journal Article
Open access
PDF file
AKAmanda F. Khan
Amanda F. Khan
SAStefan Allen
Stefan Allen
IGIan Gerard
Ian Gerard
RBRhys Beaudry
Rhys Beaudry
GBGlen Bandiera
Glen Bandiera
SLShaun Loewen
Shaun Loewen
Background: This study’s objective was to be the first to explore the ethnicity/cultural origins, gender identity, ability/disability, sexual orientation, socioeconomic background, and harassment/discrimination experiences of Canadian radiation oncologists (ROs). Methods: Following a literature review and input from content experts, an ethics-approved national cross-sectional electronic survey was developed in English and French and electronically distributed to all ROs in Canada (n = 598). Descriptive statistics summarized responses. Comparisons between groups were performed using Chi-square tests, and content analysis was performed on open-ended responses. Results: The survey was completed in full by 42.5% of ROs (254/598). Most respondents were male (62.9%), 35–44 years old (39.2%), and heterosexual (94.3%). 41.2% identified as belonging to a racialized group, which is higher than the overall Canadian population (27%), but Black, Indigenous, and Southeast Asian ROs were underrepresented (1.9% vs. 4%, <1% vs. 5% and 1.6% compared to 4%, respectively). A significant subset analysis showed that only 20% (21/105) of racialized ROs were women, whereas Caucasian women comprised 49.3% (74/150) of Caucasian respondents (p < 0.001). While 75.4% of respondents reported job satisfaction, 42.1% reported experiencing workplace discrimination/harassment within the past 5 years; most commonly, this was perpetrated by fellow faculty (31.7%; 58/183) or patients or their family members (31.7%; 58/183). Respondents felt that gender, race/ethnicity, and age were the three top reasons for discrimination/harassment, with double the amount of racialized ROs reporting harassment compared to White ROs (p < 0.001). Nearly half (45.2%; 114/252) did not understand how to report, or felt uncomfortable reporting, workplace discrimination/harassment. Conclusions: This study highlights high harassment and discrimination rates amongst Canadian ROs, especially amongst racialized women, which may affect career satisfaction and attrition rates. Compared to census data, Black, Indigenous, and Southeast Asian ROs were underrepresented, and amongst racialized ROs, racialized women were significantly underrepresented. These findings underscore the need for targeted diversity initiatives, improved mentorship programs, and stronger institutional policies to address harassment and foster an inclusive work environment.

6 November 2025 in Current Oncology
Verified
Journal Article
Open access
PDF file
SAStefan Allen
Stefan Allen
AKAmanda Khan
Amanda Khan
JRJolie Ringash
Jolie Ringash
DBDavid Bowes
David Bowes
RJReshma Jagsi
Reshma Jagsi
JCJennifer Croke
Jennifer Croke
Background: This study characterizes the current representation of sociodemographic groups within Canadian radiation oncology training programs and trainees’ lived experiences. Methods: A 59-item ethics-approved, bilingual survey assessed sociodemographics, training perceptions, mentorship, discrimination/harassment experienced, and open-ended questions. Electronic surveys were distributed to all Canadian radiation oncology residents/fellows. Descriptive statistics summarized survey responses. Categorical groups were compared using chi-squared/Fisher’s exact tests. Thematic analysis was performed on open-ended responses. Results: Between July and December 2023, 98 of 177 (56%) trainees participated: 70% were residents, 52% identified as male, 62% as a racialized minority, and 10% as a sexual minority. Most respondents reported training program satisfaction (83%) and a respectful workplace culture (69%); however, discrimination during training was reported by 38%. Less than half (45%) felt comfortable reporting discrimination/harassment within their workplace. Women were more likely to feel under-represented in-training (46% vs. 13%, p = 0.001) and perceived more discrimination events (64% vs. 19%, p < 0.001). Three themes emerged as follows: importance of offering EDI education, ensuring pathways for reporting learner mistreatment, and creating appropriately diverse selection committees. Conclusions: Although most Canadian radiation oncology trainees reported satisfaction and a respectful culture, key differences between groups were observed. Targeted strategies and stronger institutional policies to improve representation and reduce rates of discrimination/harassment are needed.